FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

73579000: Carbidopa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
122178011 Carbidopa en Synonym Active Entire term case insensitive SNOMED CT core module
122179015 MK-486 en Synonym Active Entire term case sensitive SNOMED CT core module
813982014 Carbidopa (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3736797013 Alpha-methyldopa hydrazine en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbidopa Is a Co-careldopa false Inferred relationship Existential restriction modifier
Carbidopa Is a Antiparkinsonian agent false Inferred relationship Existential restriction modifier
Carbidopa Is a Co-careldopa false Inferred relationship Existential restriction modifier
Carbidopa Is a Dihydroxyphenylalanine true Inferred relationship Existential restriction modifier
Carbidopa Is a Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Carbidopa Has disposition Dopamine receptor agonist true Inferred relationship Existential restriction modifier
Carbidopa Has disposition Dihydroxyphenylalanine decarboxylase inhibitor true Inferred relationship Existential restriction modifier
Carbidopa Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sinemet 10mg/100mg tablets (Organon Pharma (UK) Ltd) 100 tablet 10 x 10 tablets Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg/5ml oral suspension 100 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg/5ml oral suspension (Drug Tariff Special Order) 100 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Waymade Healthcare Plc) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Waymade Healthcare Plc) 50 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Lecado 100mg/25mg modified-release tablets (Sandoz Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Lecado 200mg/50mg modified-release tablets (Sandoz Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Lecado 100mg/25mg modified-release tablets (Sandoz Ltd) 60 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Lecado 200mg/50mg modified-release tablets (Sandoz Ltd) 60 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Waymade Healthcare Plc) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Waymade Healthcare Plc) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg/5ml oral suspension 100 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg/5ml oral suspension (Special Order) 100 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Waymade Healthcare Plc) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Waymade Healthcare Plc) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Cubic Pharmaceuticals Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Cubic Pharmaceuticals Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Cubic Pharmaceuticals Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Cubic Pharmaceuticals Ltd) 50 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Cubic Pharmaceuticals Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Doncaster Pharmaceuticals Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Doncaster Pharmaceuticals Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Doncaster Pharmaceuticals Ltd) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Doncaster Pharmaceuticals Ltd) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (AM Distributions (Yorkshire) Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (AM Distributions (Yorkshire) Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (AM Distributions (Yorkshire) Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (J M McGill Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (J M McGill Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Niche Pharma Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Niche Pharma Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Niche Pharma Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Niche Pharma Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (DE Pharmaceuticals) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (DE Pharmaceuticals) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (CST Pharma Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (CST Pharma Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (DE Pharmaceuticals) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (DE Pharmaceuticals) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (CST Pharma Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (CST Pharma Ltd) 50 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (CST Pharma Ltd) 100 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (CST Pharma Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Colorama Pharmaceuticals Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Icarus Pharmaceuticals Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Icarus Pharmaceuticals Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Colorama Pharmaceuticals Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Icarus Pharmaceuticals Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Icarus Pharmaceuticals Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Apodespan PR 50mg/200mg tablets (Accord Healthcare Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Apodespan PR 50mg/200mg tablets (Accord Healthcare Ltd) 60 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Ennogen Healthcare Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Ennogen Healthcare Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg/5ml oral suspension 100 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg/5ml oral suspension (Drug Tariff Special Order) 100 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Colorama Pharmaceuticals Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Pharma-z Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Pharma-z Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Colorama Pharmaceuticals Ltd) 100 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Colorama Pharmaceuticals Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Pharma-z Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Pharma-z Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg modified-release tablets (Ennogen Healthcare Ltd) 50 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Ennogen Healthcare Ltd) Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets (Ennogen Healthcare Ltd) 60 tablet Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Mawdsley-Brooks & Company Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Mawdsley-Brooks & Company Ltd) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Sinemet 25mg/250mg tablets (Waymade Healthcare Plc) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 3.125mg/12.5mg/5ml oral suspension Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 5mg/50mg/5ml oral suspension Has basis of strength substance False Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 3.125mg/12.5mg/5ml oral suspension (Special Order) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 5mg/50mg/5ml oral suspension (Special Order) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 5mg/50mg/5ml oral suspension 1 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 3.125mg/12.5mg/5ml oral suspension 1 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 3.125mg/12.5mg/5ml oral suspension (Special Order) 1 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 5mg/50mg/5ml oral suspension (Special Order) 1 ml Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Zentiva Pharma UK Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Zentiva Pharma UK Ltd) 100 tablet 10 x 10 tablets Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (A A H Pharmaceuticals Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Alliance Healthcare (Distribution) Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (A A H Pharmaceuticals Ltd) 90 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Alliance Healthcare (Distribution) Ltd) 90 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Zentiva Pharma UK Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Zentiva Pharma UK Ltd) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Zentiva Pharma UK Ltd) 100 tablet 10 x 10 tablets Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Zentiva Pharma UK Ltd) 100 tablet 10 x 10 tablets Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Somex Pharma) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Somex Pharma) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Somex Pharma) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Somex Pharma) Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Somex Pharma) 90 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 10mg/100mg tablets (Somex Pharma) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Somex Pharma) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier
Co-careldopa 25mg/250mg tablets (Somex Pharma) 100 tablet Has basis of strength substance True Carbidopa Inferred relationship Existential restriction modifier

Start Previous Page 12 of 13 End

This concept is not in any reference sets

Back to Start